These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 210706)

  • 21. [Addison's disease cured after antitubercular antibiotherapy. Hormone study and discussion].
    Laroche C; Grégoire J; Fournier A
    Sem Ther; 1968 May; 44(5):303-7. PubMed ID: 4300752
    [No Abstract]   [Full Text] [Related]  

  • 22. Diminished growth hormone secretion in blind males after L-dopa stimulation.
    Fatranská M; Jurcovicová J; Németh S; Vigas M
    Endocrinol Exp; 1988 Dec; 22(4):243-8. PubMed ID: 3243205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of plasma ACTH levels with corticosteroids in Addison's disease.
    Holdaway IM
    Clin Endocrinol (Oxf); 1973 Jan; 2(1):37-42. PubMed ID: 4358776
    [No Abstract]   [Full Text] [Related]  

  • 24. The effect of dihydroergotoxine-ethanesulphonate (Redergam) on the basal and with 3-(3,4-dihydroxyphenyl)-L-alanine (L-DOPA) stimulated somatotrophic secretion of diabetic patients.
    Dobrew D; Zonew I; Milanow S
    Ther Hung; 1977; 25(4):145-9. PubMed ID: 605413
    [No Abstract]   [Full Text] [Related]  

  • 25. [Problems of physiopathology and diagnosis in Addison's disease].
    Milcu SM; Stan M; Mănciulescu D
    Stud Cercet Endocrinol; 1968; 19(5):335-79. PubMed ID: 4304598
    [No Abstract]   [Full Text] [Related]  

  • 26. Pulsatile thyrotropin secretion in patients with Addison's disease during variable glucocorticoid therapy.
    Hangaard J; Andersen M; Grodum E; Koldkjaer O; Hagen C
    J Clin Endocrinol Metab; 1996 Jul; 81(7):2502-7. PubMed ID: 8675567
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of a met-enkephalin analog on adrenocorticotropin (ACTH), growth hormone, and prolactin in patients with ACTH hypersecretion.
    Allolio B; Winkelmann W; Hipp FX; Kaulen D; Mies R
    J Clin Endocrinol Metab; 1982 Jul; 55(1):1-7. PubMed ID: 6281297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A short negative feedback mechanism regulating corticotropin-releasing hormone release.
    Suda T; Tomori N; Yajima F; Ushiyama T; Sumitomo T; Nakagami Y; Demura H; Shizume K
    J Clin Endocrinol Metab; 1987 May; 64(5):909-13. PubMed ID: 3031120
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A clinical study of Addison's disease.
    De Rosa G; Corsello SM; Cecchini L; Della Casa S; Testa A
    Exp Clin Endocrinol; 1987 Sep; 90(2):232-42. PubMed ID: 2828083
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Probable pituitary adenoma with adrenocorticotropin hypersecretion (corticotropinoma) secondary to Addison's disease.
    Jara-Albarran A; Bayort J; Caballero A; Portillo J; Laborda L; Sampedro M; Cure C; Mateos JM
    J Clin Endocrinol Metab; 1979 Aug; 49(2):236-41. PubMed ID: 222793
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The effect of somatostatin on the rise of growth hormone and glucagon secretion induced by arginine and L-dopa in diabetic patients.
    Hansen AP; Christensen SE; Lundbaek K
    Scand J Clin Lab Invest; 1975 May; 35(3):205-10. PubMed ID: 1153917
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Growth hormone concentration during sleep following L-dopa administration].
    Blaim A; Kulesza B; Palinska-Cudnoch M
    Endokrynol Pol; 1976; 27(5):457-62. PubMed ID: 991841
    [No Abstract]   [Full Text] [Related]  

  • 33. [Adrenal response to ACTH administration in normal subjects, in patients with Addison's disease and in patients chronically treated with steroids (author's transl)].
    Arteaga E; López JM; Godoy R; Silva R
    Rev Med Chil; 1980 Feb; 108(2):109-11. PubMed ID: 6264560
    [No Abstract]   [Full Text] [Related]  

  • 34. The nature of the circadian periodicity and suppressibility of immunoreactive ACTH levels in Addison's disease.
    Krieger DT; Gewirtz GP
    J Clin Endocrinol Metab; 1974 Jul; 39(1):46-52. PubMed ID: 4365917
    [No Abstract]   [Full Text] [Related]  

  • 35. Addison's Diseases.
    Harbuwono DS; Edi TJ; Suyono S; Subekti I
    Acta Med Indones; 2009 Jan; 41(1):36. PubMed ID: 19258679
    [No Abstract]   [Full Text] [Related]  

  • 36. [Abnormalities of the hypothalamo-pituitary axis in Addison's disease--a case report].
    Jeng CY; Shen DC; Bian TY; Shian LR; Huang HW
    Taiwan Yi Xue Hui Za Zhi; 1985 Jan; 84(1):135-40. PubMed ID: 3923154
    [No Abstract]   [Full Text] [Related]  

  • 37. Comparative effects of glucagon and arginine upon growth hormone secretion in children and adolescents.
    Santander R; Coll García E
    Acta Cient Venez; 1977; 28(4):290-4. PubMed ID: 920023
    [No Abstract]   [Full Text] [Related]  

  • 38. L-Dopa Stimulates Cortisol Secretion through Adrenocorticotropic Hormone Release in Short Children.
    Marakaki C; Papadimitriou DT; Kleanthous K; Papadopoulou A; Papadimitriou A
    Horm Res Paediatr; 2015; 84(5):319-22. PubMed ID: 26393346
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effect of prolonged administration of CRF on plasma concentrations of ACTH in patients with Addison's disease.
    Pirich K; Vierhapper H; Nowotny P; Waldhäusl W
    Exp Clin Endocrinol; 1986 Jul; 87(2):208-10. PubMed ID: 3019743
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of cyproheptadine on the spontaneous diurnal variations of plasma ACTH-cortisol and ACTH-GH secretion induced by l-dopa.
    Delitala G; Masala A; Alagna S; Devilla L
    Biomedicine; 1975 Dec; 23(10):406-9. PubMed ID: 177112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.